日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Simultaneous Imaging of Cu(+) and Cu(2) (+) in Neural Cells Using DNAzyme Probes Reveals Mechanistic Link Between Copper Redox Imbalance and Amyloid Pathology

利用DNA酶探针同时成像神经细胞中的Cu(+)和Cu(2)(+)揭示铜氧化还原失衡与淀粉样蛋白病理之间的机制联系

Shao, Xiangli; Yang, Zhenglin; Xu, Zhihao; Guo, Weijie; Lewis, Whitney; Gan, Boyi; Lu, Yi

Oestradiol-mediated ferroptosis defense shapes sex differences in acute kidney injury

雌二醇介导的铁死亡防御机制影响急性肾损伤中的性别差异

Wu, Shengrong; Zhuang, Li; Gan, Boyi

Germline inactivation of tumor suppressor BAP1 is associated with white spotting

肿瘤抑制基因BAP1的种系失活与白斑病有关

Njauw, Ching-Ni; Ji, Zhenyu; Latoni, David I; Villa-Gonzalez, Jose Mari; McCormick, Shelley; Kumar, Raj; Usoltsev, Dmitrii; Artomov, Mykyta; Gan, Boyi; Tsao, Hensin

Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance.

放射疗法可促进铜细胞凋亡,并与铜细胞凋亡诱导剂协同作用,克服肿瘤放射抗性

Lei Guang, Sun Mingchuang, Cheng Jun, Ye Rui, Lu Zhengze, Horbath Amber, Huo David, Wu Shengrong, Alapati Anagha, Aggarwal Sadhna, Xu Zhihao, Mao Chao, Yan Yuelong, Yao Jun, Li Qidong, Chen Xiong, Lee Hyemin, Zhuang Li, Jiang Dadi, Pataer Apar, Roth Jack A, Navin Nicholas, Koong Albert C, You Mingjian James, Lin Steven H, Gan Boyi

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

CHD1 缺失会重编程 SREBP2 驱动的胆固醇合成,从而促进 SPOP 突变前列腺肿瘤的雄激素反应性生长和去势抵抗

Chen Feiyu, Li Haoyan, Wang Yin, Tang Ximing, Lin Kevin, Li Qidong, Meng Chenling, Shi Wei, Leo Javier, Liang Xin, Zhang Jie, Van Vivien, Mahmud Iqbal, Wei Bo, Lorenzi Philip L, Raso Maria G, Aparicio Ana, Lu Yue, Frigo Daniel E, Gan Boyi, Zhao Di

Disulfidptosis and its emerging relevance in cancer and immunity

二硫键断裂及其在癌症和免疫学中的新兴意义

Li, Qidong; Wu, Shengrong; Zhuang, Li; Gan, Boyi

A guideline on the molecular ecosystem regulating ferroptosis

关于调控铁死亡的分子生态系统的指南

Dai, Enyong; Chen, Xin; Linkermann, Andreas; Jiang, Xuejun; Kang, Rui; Kagan, Valerian E; Bayir, Hülya; Yang, Wan Seok; Garcia-Saez, Ana J; Ioannou, Maria S; Janowitz, Tobias; Ran, Qitao; Gu, Wei; Gan, Boyi; Krysko, Dmitri V; Zhu, Xiaofeng; Wang, Jiayi; Krautwald, Stefan; Toyokuni, Shinya; Xie, Yangchun; Greten, Florian R; Yi, Qing; Schick, Joel; Liu, Jiao; Gabrilovich, Dmitry I; Liu, Jinbao; Zeh, Herbert J; Zhang, Donna D; Yang, Minghua; Iovanna, Juan; Kopf, Manfred; Adolph, Timon E; Chi, Jen-Tsan; Li, Changfeng; Ichijo, Hidenori; Karin, Michael; Sankaran, Vijay G; Zou, Weiping; Galluzzi, Lorenzo; Bush, Ashley I; Li, Binghui; Melino, Gerry; Baehrecke, Eric H; Lotze, Michael T; Klionsky, Daniel J; Stockwell, Brent R; Kroemer, Guido; Tang, Daolin

Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities

探索诱导铁死亡疗法在癌症治疗中的应用:挑战与机遇

Lei, Guang; Gan, Boyi

Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers.

揭示 ETC 复合物 I 在铁死亡中的作用,为 LKB1 缺陷型癌症提供了一种潜在的诱导铁死亡的治疗策略

Mao Chao, Lei Guang, Horbath Amber, Wang Min, Lu Zhengze, Yan Yuelong, Liu Xiaoguang, Kondiparthi Lavanya, Chen Xiong, Cheng Jun, Li Qidong, Xu Zhihao, Zhuang Li, Fang Bingliang, Marszalek Joseph R, Poyurovsky Masha V, Olszewski Kellen, Gan Boyi

Rewiring cancer cell death: LPCAT1 shapes lipid composition and ferroptosis resistance

重塑癌细胞死亡:LPCAT1 调控脂质组成和铁死亡抵抗力。

Lee, Hyemin; Zhuang, Li; Gan, Boyi